Total Funding
9
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Resilience Therapeutics focuses on developing small molecule therapeutics for psychiatric conditions.
About the Company
Resilience Therapeutics is an operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditions. The company develops therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders. Its drug discovery engine focuses on developing
therapeutics that provide both symptom relief and potential disease modification for PTSD and other Stress-Related Disorders, providing medical practitioners with therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders.
Founded in 2014, Resilience Therapeutics is headquartered in Boston, Massachusetts.
Women Founded
